ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 642295 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 642295; 2) Community: the network communities that were significantly associated with the response to NSC 642295; 3) Molecule: the relationships between components within communities and NSC 642295; 4) MDR: the compounds that were significantly associated with the NSC 642295.

NSC Compound Enrichment Correlation
NSC 145669 4(1H)-Quinazolinone, 2,3-dihydro-2-(1-naphthalenyl)- (9CI) 0.0393863597626316 0.27039547
NSC 16166 Azure B bromide 0.0393863597626316 -0.10247216
NSC 167406 .beta.-Ursolic acid 0.0393863597626316 0.089127942
NSC 188491 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.0393863597626316 -0.094850436
NSC 20527 5-Bromosalicylic acid p-bromoanilide 0.0393863597626316 0.19376749
NSC 20644 Null 0.0393863597626316 0.054576097
NSC 244708 Benzoic acid, 3,5-dinitro-4-(1H-purin-6-ylthio)-, ethyl ester 0.0393863597626316 0.032411508
NSC 269719 Estr-4-en-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (17.beta.)- 0.0393863597626316 0.36051263
NSC 304421 LEUROSINE-N-OXIDE 0.0393863597626316 0.45592533
NSC 3074 s-Triazine, 4,6-diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0393863597626316 0.007567435
Total:37  Current:27    [First] [Prev] [Next] [Last]